A preliminary study of tricyclic antidepressant (TCA) ovine FAB for TCA toxicity

Clinical Toxicology

Volumn 44, Issue 3, 2006, Pages 275-281

  Heard, Kennon ^a,b,g   Dart, Richard ^a,b   Bogdan, Gregory ^b,c   O'Malley, Gerald ^b,c   Burkhart, Keith K ^d   Donovan, J Ward ^e   Ward, Suzanne B ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^c ALBERT EINSTEIN MEDICAL CENTER   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e Harrisburg Hospital   (United States)

^f BIOCOMPATIBLES UK LTD   (United Kingdom)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody Fragments; Cardiovascular poisoning; FAB; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTIBODY; DESIPRAMINE; IMIPRAMINE; NORTRIPTYLINE; SALBUTAMOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT ANTIBODY FRAGMENT; UNCLASSIFIED DRUG; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLOGIC FACTOR;

ADULT; ANAPHYLAXIS; ARTICLE; ASTHMA; CARDIOTOXICITY; CLINICAL TRIAL; COUGHING; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INTOXICATION; FEMALE; HEART ARRHYTHMIA; HEART RATE; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; QRS COMPLEX; SERUM SICKNESS; WHEEZING; ANIMAL; BLOOD; IMMUNOLOGY; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROSPECTIVE STUDY; SHEEP; TREATMENT OUTCOME;

ANIMALIA; OVIS;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POISONING; PROSPECTIVE STUDIES; SHEEP; TREATMENT OUTCOME;

EID: 33745105695     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650600584428     Document Type: Article

References (18)

1. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2004; 22:335-404.
2. Ellison DW, Pentel PR. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989; 7:5-10.
3. Liebelt EL, Francis PD. Cyclic Antidepressants. In: Goldfrank LS, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's Toxicologic Emergencies, 7. New York: McGraw-Hill, 2003:847-865.
4. Hoffman JR, Votey SR, Bayer M, Silver L. Effect of sodium bicarbonate in the treatment of moderate to severe cyclic antidepressant overdose. Am J Emerg Med 1993; 11:336-341.
5. Albertson TE, Dawson A, de Latorre F, Hoffman RS, Hollander JE, Jaeger A, Kerns WR. 2nd, Martin TG, Ross MP. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001; 37(4 Suppl):S78-90.
6. Tran TP, Panacek EA, Rhee KJ, Foulke GE. Response to dopamine vs norepinephrine in tricyclic antidepressant-induced hypotension. Acad Emerg Med 1997; 4:864-8.
7. Antman EM, Wenger TI, Butler VP, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin specific Fab: final report of mulitcenter study. Circulation 1990; 81:1744-1752.
8. Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, Kirkpatrick CH, Strauss HC, Smith TW. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 1991; 17:590-8.
9. Pentel PR, Keyler DE, Brunn GJ, Milavetz JM, Gilbertson DG, Matta SG, Pond SM. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship. Drug Metab Dispos 1991; 19:24-8.
10. Hursting MJ, Opheim KE, Raisys VA, Kenny MA, Metzger G. Tricyclic antidepressant-specific Fab fragments alter the distribution and elimination of desipramine in the rabbit: a model for overdose treatment. Clin Toxicol 1989; 27:53-66.
11. Brunn GJ, Keyler DE, Pond SM, Pentel PM. Reversal of desipramine toxicity in rats using drug specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate. J Pharmacol Exper Ther 1992; 260:1392-1399.
12. Pentel PR, Scarlett W, Ross CA, Landon J, Sidki A, Keyler DE. Reduction of desipramine cardiotoxicity and prolongation of survival in rats with the use of polyclonal drug-specific antibody Fab fragments. Ann Emerg Med 1995; 26:334-41.
13. Dart RC, Sidki A, Sullivan JB, Egen NB, Garcia RA. Ovine desipramine antibody fragments reverse desipramine cardiovascualr toxicity in the rat. Ann Emerg Med 1996; 27:309-315.
14. Heard K, O'Malley GF, Dart RC. Treatment of amitriptyline toxicity with a tricyclic antidepressant immune ovine Fab. Lancet 1999; 354:1614-1615.
15. Hurst HE, Jarboe CH. Clinical findings, elimination pharmacokinetics, and tissue drug concentrations following a fatal amitriptyline intoxication. Clin Toxicol 1981; 18:119-25.
16. Brunn GJ, Keyler DE, Ross CA, Pond SM, Pentel PR. Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in rats. Int J Immunopharmacol 1991; 13:841-51.
17. Colburn WA. Specific antibodies and Fab fragments to alter pharmacologic/toxicologic effects of drugs. Drug Metabol Rev 1980; 11:223-262.
18. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, Ward SB, Porter RS. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 2001; 161:2030-6.